Lmr Partners LLP Amgen Inc Put Options Transaction History

Lmr Partners LLP

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 07, 2024	BUY	$309.38 - $337.38 $49.3 Million - $53.8 Million	159,400 Added 1594.0%	169,400 $54.6 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $24.1 Million - $29.1 Million	-89,700 Reduced 89.97%	10,000 $2.84 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $6.45 Million - $8.01 Million	29,500 Added 42.02%	99,700 $26.8 Million
Q2 2023 Aug 14, 2023	BUY	$214.27 - $253.37 $15 Million - $17.8 Million	70,200 New	70,200 $15.6 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.